The WHO Classification of Haematolymphoid Tumours.
作者信息
Cree Ian A
机构信息
International Agency for Research on Cancer (IARC), World Health Organization, 150 Cours Albert Thomas, Lyon, 69372, France.
出版信息
Leukemia. 2022 Jul;36(7):1701-1702. doi: 10.1038/s41375-022-01625-x. Epub 2022 Jun 22.
Abstract
摘要
相似文献
1
The WHO Classification of Haematolymphoid Tumours.世界卫生组织血液淋巴系统肿瘤分类
Leukemia. 2022 Jul;36(7):1701-1702. doi: 10.1038/s41375-022-01625-x. Epub 2022 Jun 22.
2
[Pay attention to the updates of 5th edition WHO classification of haematolymphoid tumours].关注世界卫生组织血液淋巴系统肿瘤分类第5版的更新内容。
Zhonghua Bing Li Xue Za Zhi. 2024 Jan 8;53(1):3-5. doi: 10.3760/cma.j.cn112151-20230822-00088.
3
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版：淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
4
Response to "The WHO classification of haematolymphoid tumours" (Editorial).对《世界卫生组织血液淋巴系统肿瘤分类》（社论）的回应
Leukemia. 2022 Nov;36(11):2748-2749. doi: 10.1038/s41375-022-01689-9. Epub 2022 Aug 27.
5
The WHO classification of haematolymphoid tumours: response to Swerdlow et al.世界卫生组织血液淋巴系统肿瘤分类：对斯韦德洛等人的回应
Leukemia. 2022 Nov;36(11):2750. doi: 10.1038/s41375-022-01694-y. Epub 2022 Sep 28.
6
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
7
[Interpretation of myeloid neoplasms in the 5th WHO classification of haematolymphoid tumors].[《世界卫生组织血液淋巴系统肿瘤分类第5版中髓系肿瘤的解读》]
Zhonghua Bing Li Xue Za Zhi. 2024 Apr 8;53(4):323-330. doi: 10.3760/cma.j.cn112151-20230823-00093.
8
Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification.成熟 B、T 和 NK 细胞、浆细胞和组织细胞/树突状细胞肿瘤：根据世界卫生组织和国际共识分类的分类。
J Hematol Oncol. 2024 Jul 8;17(1):51. doi: 10.1186/s13045-024-01570-5.
9
[Interpretation of lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation in the 5th edition WHO classification of haematolymphoid tumours].[《世界卫生组织血液淋巴系统肿瘤分类第5版中与免疫缺陷和失调相关的淋巴样增殖和淋巴瘤的解读》]
Zhonghua Bing Li Xue Za Zhi. 2024 Jul 8;53(7):651-654. doi: 10.3760/cma.j.cn112151-20230908-00152.
10
[Interpretation of T-cell and NK-cell lymphoid proliferations and lymphomas in the 5th edition of the WHO classification of haematolymphoid tumours].[《世界卫生组织血液淋巴系统肿瘤分类》第5版中T细胞和NK细胞淋巴样增殖及淋巴瘤的解读]
Zhonghua Bing Li Xue Za Zhi. 2024 Jun 8;53(6):535-540. doi: 10.3760/cma.j.cn112151-20230823-00094.
引用本文的文献
1
Regulators of Cancer Progression: Succinylation.癌症进展的调节因子：琥珀酰化作用
Cancers (Basel). 2025 Aug 14;17(16):2652. doi: 10.3390/cancers17162652.
2
Primary central nervous system Burkitt lymphoma in a 38-year-old immunocompetent woman: A case report.一名38岁免疫功能正常女性的原发性中枢神经系统伯基特淋巴瘤：病例报告
Medicine (Baltimore). 2025 Apr 25;104(17):e42321. doi: 10.1097/MD.0000000000042321.
3
Unveiling the Complexity of Rearrangements in Acute Myeloid Leukemias with Optical Genome Mapping.利用光学基因组图谱揭示急性髓系白血病重排的复杂性
Cancers (Basel). 2024 Dec 14;16(24):4171. doi: 10.3390/cancers16244171.
4
A novel prognostic scoring system for AML patients undergoing allogeneic hematopoietic stem cell transplantation with real world validation.一种用于接受异基因造血干细胞移植的急性髓系白血病患者的新型预后评分系统及真实世界验证。
J Adv Res. 2025 Jul;73:671-679. doi: 10.1016/j.jare.2024.09.014. Epub 2024 Sep 18.
5
Management of Advanced Systemic Mastocytosis: Clinical Challenges.晚期系统性肥大细胞增多症的管理：临床挑战
J Blood Med. 2024 Sep 11;15:421-433. doi: 10.2147/JBM.S366367. eCollection 2024.
6
Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia.整合多组学数据以识别慢性淋巴细胞白血病中失调的分子途径和可成药靶点
J Pers Med. 2024 Aug 6;14(8):831. doi: 10.3390/jpm14080831.
7
Mechanobiology and Primary Cilium in the Pathophysiology of Bone Marrow Myeloproliferative Diseases.机械生物学和初级纤毛在骨髓增殖性疾病发病机制中的作用。
Int J Mol Sci. 2024 Aug 14;25(16):8860. doi: 10.3390/ijms25168860.
8
Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy.儿童造血系统恶性肿瘤遗传易感性监测建议的更新。
Clin Cancer Res. 2024 Oct 1;30(19):4286-4295. doi: 10.1158/1078-0432.CCR-24-0685.
9
A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC.关于髓系肿瘤和急性白血病分类的实用方法：WHO 和 ICC。
J Hematol Oncol. 2024 Jul 29;17(1):56. doi: 10.1186/s13045-024-01571-4.
10
Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification.成熟 B、T 和 NK 细胞、浆细胞和组织细胞/树突状细胞肿瘤：根据世界卫生组织和国际共识分类的分类。
J Hematol Oncol. 2024 Jul 8;17(1):51. doi: 10.1186/s13045-024-01570-5.
Zotero 插件